Senior insider sale
Chief Operating Officer at ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$128.3K
36.66K shares
What this filing means
STEVENS CHRISTOPHER JAMES plans to sell 36.66K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $128.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/11/2026ACC: 0001959173-26-005892
Officer· Chief Operating Officer
Since Feb 2026
36.66K
Shares to sell
$128.3K
Approx. market value
36.66K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
8/4/2026
36.66KTotal acquired36.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/4/2026 | Restricted Stock Vesting Compensation | 36.66K | — |
| Total | 36.66K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
36.66K
Market value
$128.3K
8/11/2026
Total
Units
36.66K
Value
$128.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/11/2026 | 36.66K | $128.3K | NASDAQ | Planned |
| Total | 36.66K | $128.3K | ||